The prognostic value of CD38 expression and its quantification in B cell chronic lymphocytic leukemia (B-CLL)

Leukemia and Lymphoma

Volumn 45, Issue 3, 2004, Pages 455-462

  Mainou Fowler, Tryfonia ^a   Dignum, Helen M ^a   Proctor, Stephen J ^a   Summerfield, Geoffrey P ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

CD38 quantification; Chronic lymphocytic leukemia

Indexed keywords

BETA 2 MICROGLOBULIN; CD23 ANTIGEN; CD38 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; MEMBRANE ANTIGEN; PROTEIN KINASE ZAP 70; PROTEIN P53;

ANALYTIC METHOD; ANALYTICAL PARAMETERS; ANTIBODY AFFINITY; ANTIGEN BINDING; ANTIGEN EXPRESSION; B CELL LEUKEMIA; BONE MARROW BIOPSY; CANCER STAGING; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; CORRELATION ANALYSIS; CYTOGENETICS; FLOW CYTOMETRY; FLUORESCENCE; GENE MUTATION; HUMAN; LYMPHOCYTIC INFILTRATION; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TUMOR GROWTH;

ADP-RIBOSYL CYCLASE; ANTIGENS, CD; ANTIGENS, CD38; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, B-CELL, CHRONIC; MEMBRANE GLYCOPROTEINS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 1042268887     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819032000141275     Document Type: Review

References (74)

1. Rai, K. and Patel, D. (1995) Chronic lymphocytic leukaemia. In Hematology: Basic Principles and Practice, edited by R. Hoffman, E. Benz, S.Shattil, B. Furle, H. Cohen and L. Silberstein. Pp. 1308-1321. New York: Churchill Livingstone.
2. Matutes, E., Owusu-Ankomah, K., Morilla, R., Marco, J.G., Houlihan, A., Que, T.H., et al. (1994) "The immunological profile of B cell disorders and proposal of a scoring system for the diagnosis of CLL", Leukemia, 8, 1640-1645.
3. Matutes, E. and Polliack, A. (2000) "Morphological and immunophenotypic features of chronic lymphocytic, leukemia", Reviews in Clinical and Experimental Hematology, 4, 22-47.
4. Kipps, T.J., Tomhave, E., Pratt, L.F., Duffy, S., Chen, P.P. and Carson, D.A. (1989) "Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia", Proceedings of the National Academy of Science USA, 86, 5913-5917.
5. H 1 genes in human B-lineage leukemias", Leukemia, 5, 646-650.
6. + chronic lymphocytic, leukemia B cells", Journal of Experimental Medicine, 181, 1507-1517.
7. Fais, F., Ghiotto, F., Hashimoto, S., Sellars, B., Valleto, A., Allen, S.L., et al. (1998) "Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors", Journal of Clinical Investigation, 102, 1515-1525.
8. Zwiebel, J.A. and Cheson, B.D. (1998) "Chronic Lymphocytic Leukemia: staging and prognostic factors", Seminars in Oncology, 25, 42-59.
9. Rai, K., Sawitksy, A., Cronkite, E.P., Chanana, A.D., Levy, R.N. and Pasternack, B.S. (1975) "Clinical staging of chronic lymphocytic leukemia", Blood, 46, 219-234.
10. Binet, J.L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., et al. (1981) "A new prognostic classification of chronic lymphocytic, leukaemia derived from multivariate survival analysis", Cancer, 48, 198-206.
11. Lee, J.S., Dixon, D.O., Kantarjian, H.M., Keating, M.J. and Talpaz, M. (1987) "Prognosis of chronic lymphocytic leukemia: A multivariate regression analysis of 325 untreated patients", Blood, 69, 929-936.
12. Frisch, B. and Bartl, R. (1988) "Histologic classification and staging of chronic lymphocytic leukaemia", Acta Haematologica, 79, 140-152.
13. Molica, S. and Alberti, A. (1987) "Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemia", Cancer, 60, 2712-2716.
14. Christiansen, I., Gidlof, C., Wallgren, A.C., Simonsson, B. and Totterma, T.J. (1994) "Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic lymphocytic leukemia and correlate with clinical stage and prognostic markers", Blood, 84, 3010-3016.
15. Kay, N.E., Burton, J., Wagner, D. and Nelson, D.L. (1988) "The malignant B-cells from chronic lymphocytic leukemia patients release TAC soluble interleukin-2 receptors", Blood, 72, 447-450.
16. Molica, S., Levato, D., Olio, M.D., Cascavilla, N., Matera, R., Minervini, M., et al. (1997) "Clinico-prognostic implications of increased levels of soluble CD54 in the serum of B-cell chronic lymphocytic leukaemia patients. Results of a multivariate survival analysis", Haematologica, 82, 148-151.
17. Christiansen, I., Sudstrom, C. and Totterman, T.H. (1998) "Elevated serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) closely reflect tumour burden in chronic lymphocytic leukaemia", British Journal of Haematology, 103, 1129-1137.
18. Ferrajoli, A., Keating, M.J., Manshouri, T., Giles, F.J., Dey, A., Estrov, Z., et al. (2002) "The clinical significance of tumor necrosis factor-α plasma level in patients having chronic lymphocytic leukemia", Blood, 100, 1215-1219.
19. Sarfati, M., Chevret, S., Chastang, C., Biron, G., Stryckmans, P., Derespesse, G., et al. (1998) "Prognostic importance of serum soluble CD23 levels in chronic lymphocytic leukemia", Blood, 88, 4259-4264.
20. 2-microglobulin level is more powerful than stage in predicting response and survival in chronic lymphocytic leukemia", American Society of Haematology Annual Meeting, Blood, 86, 606a.
21. Hallek, M., Langenmayer, I., Nerl, C., Knauf, W., Dietzfelbinger, H., Adorf, D., et al. (1999) "Elevated serum thymidine kinase levels identify a sub-group at high risk of disease progression in early non smoldering chronic lymphocytic leukemia", Blood, 93, 1732-1737.
22. Stilgenbauer, S., Bullinger, L., Lichter, P., Dohner, H. and The German CLL Study Group (GCLLSG) (2002) "Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course", Leukemia, 16, 993-1007.
23. Reinherz, E.L., Kung, P.C., Goldstein, G., Kumagai, M., Coustan-Smith, E. and Murray, D.J. (1980) "Discrete stages of intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T lineage", Proceedings of the National Academy of Sciences of the United States of America, 77, 1588-1592.
24. Funaro, A., Horenstein, A.L. and Malavasi, F. (1995) "Human CD38: a versatile leukocyte molecule with emerging clinical perspectives", Fundamental and Clinical Immunology, 3, 101-113.
25. Malavasi, F., Funaro, A., Alessio, M., De Monte, L.B., Ausiello, C.M., Dianzani, U., et al. (1992) "CD38: a multilineage cell activation molecule with a split personality", International Journal of Clinical and Laboratory Research, 22, 73-80.
26. Deaglio, S., Morra, M., Mallone, R., et al. (1997) "Humal CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member", Journal of Immunology, 160, 395-402.
27. Mehta, K., Shahid, U. and Malavasi, F. (1996) "Human CD38, a cell surface protein with multiple functions", FASEB Journal, 10, 1408-1417.
28. Dianzani, U., Funaro, A., Di Franco, D., Garbarino, G., Bragardo, M., Redoglia, V., et al. (1994) "Interaction between endothelium and CD4 + /CD45RA + lymphocytes", Journal of Immunology, 153, 952-959.
29. Kumogai, M., Cousan-Smith, E., Murray, D.J., Silvennoinen, O., Gopal Murti, K., Evans, W.E., et al. (1995) "Ligation of CD38 suppresses human B lymphopoiesis", Journal Experimental Medicine, 181, 1101-1110.
30. Zupo, S., Rugari, E., Dono, M., Tamborelli, G., Malavasi, F. and Ferrarini, M. (1994) "CD38 signalling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cells", European Journal of Immunology, 24, 1218-1222.
31. Gelamn, I., Dettere, P., Gouy, H., Boumsell, L., Debre, P. and Bismuth, G. (1994) "The lymphocyte antigen CD38 acts as a nicotinamide adenine dinucleotide glycohydrolase in human T lymphocytes", European Journal of Immunology, 23, 3361-3364.
32. Malavasi, F., Funaro, A., Roggero, S., Horenstein, A., Calosso, L. and Mehta, K. (1994) "Human CD38: a glycoprotein in search of a function", Immunology Today, 15, 95-97.
33. Oertel, J., Oertel, B., Schliecher, J., Schleicher, J. and Huhn, D. (1996) "Immunophenotyping of blasts in human bone marrow", Annals in Hematology, 72, 125-129.
34. Pascual, V., Liu, Y.J., Magalski, A., de Bouteiller, O., Banchereau, J. and Capra, J.D. (1994) "Analysis of somatic mutation in five B cell subsets of human tonsil", Journal Experimental Medicine, 180, 329-333.
35. Omede, P., Boccadoro, M., Gallone, G., Frieri, R., Battaglio, S., Redoglia, V., et al. (1990) "Multiple myeloma: increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor prognosis", Blood, 76, 1375-1379.
36. Keyhani, A., Huh, Y.O. and Jendiroba, D. (1999) "Increased CD38 expression is associated with favourable prognosis in adult acute leukemia", Leukemia Research, 24, 153-159.
37. Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., et al. (1999) "Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia", Blood, 94, 1840-1847.
38. Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. and Stevenson, F.K. (1999) "Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia", Blood, 94, 1848-1854.
39. Lin, K., Sherrington, P.D., Dennis, M., Matrai, Z., Cawley, J.C. and Pettitt, A.R. (2002) "Relationship between p53 dysfunction, CD38 expression and IgVH mutation in chronic lymphocytic leukemia", Blood, 100, 1404-1409.
40. Oscier, D.G., Gardiner, A.C., Mould, S.J., Glide, S., Davis, Z.A., Ibbotson, R.E., et al. (2002) "Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors", Blood, 100, 1177-1184.
41. Hamblin, T.J., Orchard, J,A., Ibbotson, R.E., Davis, Z., Thomas, P.W., Stevenson, F.K., et al. (2002) "CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease", Blood, 99, 1023-1029.
42. Jelinek, D.F., Tschumper, R.C., Geyer, S.M., Bone, N.D., Dewald, G.W., Hanson, C.A., et al. (2001) "Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia", British Journal of Haematology, 115, 854-861.
43. Krober, A., Seiler, T.L., Benner, A., Bullinger, L., Bruckle, E., Lichter, P., et al. (2002) "VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia", Blood, 100, 1410-1416.
44. Maloum, K., Davi, F., Merle-Beral, H., Pritisch, O., Magnac, C., Vuillier, F., et al. (2000) "Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia", Blood, 96, 377-379.
45. Ghia, P., Guida, G., Stella, S., Gottardi, D., Geuna, M., Strola, G., et al. (2003) "The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression", Blood, 101, 1262-1269.
46. Lanham, S., Hamblin, T., Oscier, D., Ibbotson, R., Stevenson, F. and Packham, G. (2003) "Differential signalling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia", Blood, 101, 1087-1093.
47. Thurnberg, U., Johnson, A., Roos, G., Thom, I., Tobin, G., Sallstrom, J., et al. (2001) "CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia", Blood, 97, 1892-1893.
48. Matrai, Z., Lin, K., Dennis, M., Sherrington, P., Zuzel, M., Pettitt, A.R., et al. (2001) "CD38 expression and VH gene mutation in B-cell chronic lymphocytic leukemia", Blood, 97, 1901-1902.
49. Vilpo, J., Tobin, G., Hulkkonen, J., Hurme, M., Thunberg, U., Sundstrom, C., et al. (2003) "Surface antigen expression and correlation with variable heavy-chain gene mutation status in chronic lymphocytic leukemia", European Journal of Haematology, 70, 53-59.
50. Del Poeta, G., Maurillo, L., Venditti, A., Buccisano, F., Epiceno, A.M., Capelli, G., et al. (2001) "Clinical significance of CD38 expression in chronic lymphocytic leukemia", Blood, 98, 2633-2639.
51. Mainou-Fowler, T., Dignum, H., Taylor, P.R.A., Dickinson, A., Saunders, P.W.G., Proctor, S.J., et al. (2002) "Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia", British Journal of Haematology, 118, 755-761.
52. Ibrahim, S., Keating, M., Do, K.A., O'Brien, S., Huh, Y.O., Jilani, I., et al. (2001) "CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia", Blood, 98, 181-186.
53. Chevallier, P., Penther, D., Avet-Loiseau, H., Robillard, N., Ifrah, N., Mahe, B., et al. (2002) "CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia", British Journal of Haematology, 116, 142-150.
54. D'Arena, G., Musto, P., Cascavilla, N., Dell'Olio, M., Di Renzo, N., Perla, G., et al. (2001) "CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukaemia", Leukemia and Lymphoma, 42, 109-114.
55. Domingo-Domenech, E., Domingo-Claros, A., Gonzalez-Barca, E., Beneitez, D., Alonso, E., Romagosa, V., et al. (2002) "CD38 expression in B-cell chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients", Haematologica, 87, 1021-1027.
56. Durig, J., Naschar, M., Schmucker, U., Renzing-Kohler, K., Holter, T., Huttmann, A., et al. (2002) "CD38 expression is an important prognostic marker in chronic lymphocytic leukemia", Leukemia, 16, 30-35.
57. Morabito, F., Mangiola, M., Oliva, B., Stelitano, C., Callea, V., Deaglio, S., et al. (2001) "Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia", Leukemia Research, 25, 927-932.
58. Morabito, F., Mangiola, M., Stelitano, C., Deaglio, S., Callea, V. and Malavasi, F. (2002) "Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukaemia after first-line therapy with high-dose chlorambucil", Haematologica, 87, 217-218.
59. Benet, I., Terol, MJ., Marugan, I., Martinez-Climent, J.A., Sarsotti, E., Ivars, C., et al. (2000) "CD38 expression defines clinical and biological characteristics in B-CLL", American Society of Hematology Annual Meeting, Blood, 96, 1600a.
60. Ibrahim, S., Jilani, I., O'Brien, S., Rogers, A., Manshouri, T., Giles, F., et al. (2003) "Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia", American Cancer Society, 97, 1914-1919.
61. Heintel, D., Schwarzinger, I., Chizzali-Bonfadin, C., Thalhammer, R., Schwarzmeier, J., Fritzer-Szekeres, M., et al. (2001) "Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia", Leukemia and Lymphoma, 42, 1315-1321.
62. Guarini, A., Gaidano, G., Mauro, F.R., Capello, D., Mancini, F., De Propris, M.S., et al. (2003) "Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features", Blood, 102, 1035-1041.
63. Chang, C.-C. and Cleveland, R. (2002) "Conversion of CD38 and/or myeloid-associated marker expression status during the course of B-CLL: association with a change to an aggressive clinical course", Blood, 100, 1106.
64. Gratama, JW., D'hautcourt, J.L., Mandy, F., Rothe, G., Barnett, D., Janossy, G., et al. (1998) "Flow cytometric quantification of immunofluorescence intensity: problems and perspectives". European Working Group on Clinical Cell Analysis, Cytometry, 33, 166-178.
65. + T lymphocytes as a biological calibrator", Cytometry, 33, 123-132.
66. Schwartz, A., Marti, G.E., Poon, R., Gratama, J.W. and Fernandez-Repollet, E. (1998) "Standardazing flow cytometry: a classification system of fluorescence standards used for flow cytometry", Cytometry, 33, 106-114.
67. Barnett, D., Storie, I., Granger, V., Whitby, L., Reilly, J.T., Brough, S., et al. (2000) "Standardization of lymphocyte antibody binding capacity-a multi-centre study", Clinical and Laboratory Haematology, 22, 89-96.
68. Hsi, E.D., Kopecky, K.J., Appelbaum, F.R., Boldt, D., Frey, T., Loftus, M., et al. (2003) "Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia", British Journal of Haematology, 120, 1017-1025.
69. Mainou-Fowler, T., Proctor, S.J., Miller, S. and Dickinson, A.M. (2001) "Expression and production of interleukin 4 in B-cell chronic lymphocytic leukemia", Leukemia and Lymphoma, 42, 689-698.
70. Rosenwald, A., Alizadeh, A.A., Widhopf, G., Simon, R., Davis, R.E., Yu, X., et al. (2001) "Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia", Journal of Experimental Medicine, 194, 1639-1648.
71. Wiestner, A., Rosenwald, A., Barry, T.S., Wright, G., Davis, R.E., Henrickson, S.E., et al. (2003) "ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile", Blood, 101, 4944-4951.
72. Crespo, M., Bosch, F., Villamor, N., Bellosillo, B., Colomer, D., Rozman, M., et al. (2003) "ZAP-70 expression as a surrogate for immunoglobulin-variable region mutations in chronic lymphocytic leukemia", New, England Journal of Medicine, 348, 1764-1775.
73. Chen, L., Widhopf, G., Huynh, L., Rassenti, L., Rai, K.R., Weiss, A., et al. (2002) "Expression of ZAP-70 is associated with increased B cell receptor signalling in chronic lymphocytic leukemia", Blood, 100, 4609-4514.
74. Orchard, J.A., Ibbotson, R.E., Davis, Z.A., Gardiner, A., Hamblin, T.J. and Oscier, D.G. (2002) "Zap-70 Evaluation by flow cytometry is a significant prognostic marker in B-CLL, American Society of Hematology Annual Meeting", Blood, 100, 168a.